Remarkably, metformin inhibited the mTOR activity and helped downregulating the expression of ERCC1, thus inhibiting DNA repair and overcoming the resistance of cisplatin-based chemotherapy in the LLC tumor-bearing mice 123. This evidence concerns the gene MTOR and neoplasm.